FDA elevates Vitruvia’s thyroid tablet recall to class I, its most serious risk level

FDA elevates Vitruvia’s thyroid tablet recall to class I, its most serious risk level The U. S. Food and Drug Administration has upgraded a recall of Vitruvias Therapeutics’ 30mg thyroid tablets to a class I designation. This marks the agency’s highest-risk category. ..

Read full story on Geo Tv